Cannabis
iAnthus Announces Retirement of Paul Rosen from Board of Directors
iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, announces the retirement of Paul Rosen from its Board of Directors. Mr. Rosen’s retirement comes in coordination with the Company’s previously announced slate of independent Board of Directors (“Board”). In connection with this change, the Board will be nominating Joy Chen, Mark Dowley, Diane M. Ellis, Michael P. Muldowney, and Robert M. Whelan, Jr., as new independent directors, subject to shareholder approval, during the next Annual General and Special Meeting to be held on December 5, 2019.
“It has been a pleasure to serve on the iAnthus Board of Directors during this exciting early phase of its growth. I am happy to be retiring knowing the Company is on solid footing with a strong proposed slate of new independent directors, a fully-funded business plan with a recently announced $100 million financing plan by Gotham Green Partners, an experienced management team in place, and operational momentum in all of its key states,” said Paul Rosen.
“On behalf of the entire iAnthus team, I want to thank Paul for his three years of leadership and advice as we built iAnthus to its current scale with operations across 11 states,” said Hadley Ford, iAnthus CEO. “Paul is one of most active and diversified entrepreneurs in the emerging cannabis industry. As a founder of PharmaCan Capital Corporation (now Cronos Group), BreakWater Venture Capital and most recently Pantry, Paul’s expertise and experience as a pioneer in cannabis investing was invaluable as we sought to fund our early growth. The entire iAnthus team wishes Paul our best in his future endeavors.”
SOURCE iAnthus Capital Holdings, Inc.
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth